Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NIH Grants Awarded to Oregon State, Salk Institute, and More

Premium

NIH Grants in Proteomics, July 25 to Sept. 1, Part 1 of 2 (Part 2 is available here.)

Project Title: Mass Spectrometry, Proteomics and Metabolomics Core
Contact Principal Investigator: John Asara
Organization Name: Brigham and Women's Hospital
Project Start Date: NA
Project End Date: NA
FY Total Cost: $172,953


Project Title: A Universal Electromagnetostatic Tandem-Mass-Spectrometric Dissociation-Cell
Contact Principal Investigator: Douglas Barofsky
Organization Name: Oregon State University
Project Start Date: Sept. 10, 2010
Project End Date: June 30, 2015
FY Total Cost: $339,977


Project Title: Molecular Markers for CRC Recurrence
Contact Principal Investigator: Robert Beauchamp
Organization Name: Vanderbilt University Medical Center
Project Start Date: NA
Project End Date: NA
FY Total Cost: $129,756


Project Title: RPOS-Mediated Virulence Regulation in Borrelia Burgdorferi
Contact Principal Investigator: Jon Blevins
Organization Name: University of Arkansas for Medical Sciences
Project Start Date: Aug. 23, 2013
Project End Date: April 30, 2015
FY Total Cost: $39,197


Project Title: Monospecific Monoclonal Antibodies Against Human Transcription Factors
Contact Principal Investigator: Jef Boeke
Organization Name: Johns Hopkins University
Project Start Date: Sept. 26, 2011
Project End Date: July 31, 2016
FY Total Cost: $1,777,257


Project Title: A High Throughput Pipeline to Select Renewable Recombinant Polyclonal Antibodies
Contact Principal Investigator: Andrew Bradbury
Organization Name: Los Alamos National Security-Los Alamos National Laboratory
Project Start Date: Sept. 25, 2011
Project End Date: July 31, 2014
FY Total Cost: $1,332,921


Project Title: Vaginal Microbiota, Immune Responses and Vulvovaginal Symptoms During Menopause
Contact Principal Investigator: Rebecca Brotman
Organization Name: University of Maryland Baltimore
Project Start Date: Aug. 15, 2013
Project End Date: July 31, 2015
FY Total Cost: $187,591


Project Title: Center for Polycystic Kidney Disease Research at Yale
Contact Principal Investigator: Michael Caplan
Organization Name: Yale University
Project Start Date: Sept. 30, 2010
Project End Date: June 30, 2015
FY Total Cost: $1,038,898


Project Title: Proteo-Genomic Discovery, Prioritization and Verification of Cancer Biomarkers
Contact Principal Investigator: Steven Carr
Organization Name: Broad Institute
Project Start Date: Aug. 26, 2011
Project End Date: July 31, 2014
FY Total Cost: $3,019,843


Project Title: Global Analysis of Cellular Networks Involved in Restriction of HIV Replication
Contact Principal Investigator: Sumit Chanda
Organization Name: Salk Institute for Biological Studies
Project Start Date: NA
Project End Date: NA
FY Total Cost: $978,632


Project Title: A Pipeline for Production of Bivalent Synthetic Antibodies to the Human Proteome
Contact Principal Investigator: John Chaput
Organization Name: Arizona State University-Tempe Campus
Project Start Date: Sept. 25, 2011
Project End Date: July 31, 2014
FY Total Cost: $1,264,438


Project Title: Cancer Center Support Grant
Contact Principal Investigator: Lawrence Corey
Organization Name: Fred Hutchinson Cancer Research Center
Project Start Date: Jan. 1, 1997
Project End Date: Dec. 31, 2013
FY Total Cost: $50,000


Project Title: An Immunomics Approach to Explore Drug-Induced Resistance to Schistosomes
Contact Principal Investigator: Rodrigo Correa-Oliveira,
Organization Name: Foundation for Research Development
Project Start Date: NA
Project End Date: NA
FY Total Cost: $105,160


Project Title: Modeling Drug Induced Resistance in S. Mansoni Endemic Areas
Contact Principal Investigator: Rodrigo Correa-Oliveira
Organization Name: Foundation for Research Development
Project Start Date: Aug. 1, 2012
Project End Date: July 31, 2017
FY Total Cost: $259,600


Project Title: Development of Deep Proteomic Sequencing Platforms for Molecular Markers in DLBCL
Contact Principal Investigator: Nika Danial
Organization Name: Dana-Farber Cancer Institute
Project Start Date: Aug. 1, 2013
Project End Date: July 31, 2015
FY Total Cost: $190,313


Project Title: Skin Regeneration with Stem Cells and Scaffolds
Contact Principal Investigator: Jeffrey Davidson
Organization Name: Vanderbilt University Medical Center
Project Start Date: Sept. 1, 2009
Project End Date: June 30, 2014
FY Total Cost: $601,177


Project Title: Mbnl1's Function in Myofibroblast Transformation and Fibrosis
Contact Principal Investigator: Jennifer Davis
Organization Name: Cincinnati Childrens Hospital Medical Center
Project Start Date: Aug. 9, 2013
Project End Date: July 31, 2015
FY Total Cost: $131,085


Project Title: Identification of Proteins Important for Male Osteoporosis
Contact Principal Investigator: Hong-Wen Deng
Organization Name: Tulane University of Louisiana
Project Start Date: Sept. 18, 2009
Project End Date: July 31, 2014
FY Total Cost: $537,052


Project Title: An Integrated Systems Biology Approach for Ovarian Cancer Biomarker Discovery
Contact Principal Investigator: Eleftherios Diamandis
Organization Name: Mt Sinai Hospital-Samuel Lunenfeld Research Institute
Project Start Date: Sept. 1, 2010
Project End Date: June 30, 2015
FY Total Cost: $248,982


Project Title: Biochemical & Proteomic Analysis of Cumulus Cell Secreted Zinc Inhibitory Factor
Contact Principal Investigator: Francisco Diaz
Organization Name: Pennsylvania State University
Project Start Date: Aug. 21, 2013
Project End Date: July 31, 2015
FY Total Cost: $74,750


Project Title: Understanding RTS,S Malaria Vaccine-Induced Protection through Integrated Analysis
Contact Principal Investigator: Carlota Dobano,
Organization Name: Barcelona International Health Research Center
Project Start Date: June 1, 2012
Project End Date: July 31, 2017
FY Total Cost: $569,644


Project Title: Diagonal Capillary Electrophoresis for Phosphorylation and Sialylation Analysis
Contact Principal Investigator: Norman Dovichi
Organization Name: University of Notre Dame
Project Start Date: Aug. 1, 2011
Project End Date: July 31, 2015
FY Total Cost: $275,025


Project Title: Proteomics Shared Resource
Contact Principal Investigator: Brian Druker
Organization Name: Oregon Health and Science University
Project Start Date: NA
Project End Date: NA
FY Total Cost: $48,631


Project Title: Protein Interact. Core
Contact Principal Investigator: Debra Eckert
Organization Name: University of Utah
Project Start Date: NA
Project End Date: NA
FY Total Cost: $148,797


Project Title: Cancer Proteome Center at Washington Univ, Univ Of North Carolina
Contact Principal Investigator: Matthew Ellis
Organization Name: Washington University
Project Start Date: Aug. 22, 2011
Project End Date: July 31, 2014
FY Total Cost: $2,120,962


Project Title: Mass Spectrometry Based Molecular Imaging of Native Biological Nanodomains
Contact Principal Investigator: Francisco Fernandez-Lima
Organization Name: Florida International University
Project Start Date: Aug. 1, 2010
Project End Date: July 31, 2015
FY Total Cost: $238,134


Project Title: Immunology Core
Contact Principal Investigator: Edmund Gosselin
Organization Name: Albany Medical College
Project Start Date: NA
Project End Date: NA
FY Total Cost: $237,673


Project Title: No-Modified Biomolecules and Pulmonary Signaling
Contact Principal Investigator: Andrew Gow
Organization Name: Rutgers the State University of New Jersey
Project Start Date: Sept. 1, 2006
Project End Date: May 30, 2017
FY Total Cost: $326,879


Project Title: Ethanol-Induced Protein Acylation Regulates Metabolism
Contact Principal Investigator: Matthew Hirschey
Organization Name: Duke University
Project Start Date: Aug. 5, 2013
Project End Date: June 30, 2018
FY Total Cost: $474,667


Project Title: Organ-Specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain
Contact Principal Investigator: Leroy Hood
Organization Name: California Institute of Technology
Project Start Date: NA
Project End Date: NA
FY Total Cost: $649,409


Project Title: Systems Biology Core
Contact Principal Investigator: Leroy Hood
Organization Name: California Institute of Technology
Project Start Date: NA
Project End Date: NA
FY Total Cost: $50,117


Project Title: Interpreting the Structure of the Spliceosome
Contact Principal Investigator: Melissa Jurica
Organization Name: University of California Santa Cruz
Project Start Date: June 1, 2006
Project End Date: April 30, 2017
FY Total Cost: $301,990


Project Title: Biomarkers of Neonatal Encephalopathy in a Nonhuman Primate Model
Contact Principal Investigator: Sandra Juul
Organization Name: University of Washington
Project Start Date: Aug. 1, 2013
Project End Date: May 31, 2018
FY Total Cost: $650,456


Project Title: Regulation by Proteolysis-Independent Ubiquitination
Contact Principal Investigator: Peter Kaiser
Organization Name: University of California Irvine
Project Start Date: Aug. 1, 2002
Project End Date: July 31, 2016
FY Total Cost: $115,531


Project Title: The Role of Basa Bodies in Wnt Signaling
Contact Principal Investigator: Nicholas Katsanis
Organization Name: Duke University
Project Start Date: July 1, 2006
Project End Date: July 31, 2016
FY Total Cost: $360,308


Project Title: Technology Development for Recombinant Affinity Reagents
Contact Principal Investigator: Brian Kay
Organization Name: University of Illinois
Project Start Date: Sept. 25, 2011
Project End Date: July 31, 2014
FY Total Cost: $1,118,350


Project Title: Role of ROR Proteins in the Mammalian Circadian Clock
Contact Principal Investigator: Steve Kay
Organization Name: University of Southern California
Project Start Date: April 1, 2006
Project End Date: June 30, 2015
FY Total Cost: $368,382

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.